Alex Bastian joins Memo Therapeutics AG as VP Commercial Strategy
August 27, 2024 02:00 ET
|
Memo Therapeutics AG
PRESS RELEASE Alex Bastian joins Memo Therapeutics AG as VP Commercial Strategy Seasoned commercial leader with significant international experience Joins ahead of lead development candidate...
Memo Therapeutics increases Series C financing to CHF 45 million
May 07, 2024 02:00 ET
|
Memo Therapeutics AG
PRESS RELEASE Memo Therapeutics increases Series C financing to CHF 45 million Additional CHF 20 million raised from new investors Ysios Capital and Kurma Partners as well as from existing...